Aspira Pathlab & Diagnostics Limited Stock
Equities
ASPIRA
INE500C01017
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.5 INR | +1.56% | +8.05% | -17.05% |
04-03 | Aspira Pathlab Forms New Limited Liability Partnership | MT |
04-01 | Aspira Pathlab Opens Two Diagnostic Centers in India | MT |
Sales 2022 | 195M 2.34M 3.23M | Sales 2023 | 145M 1.73M 2.39M | Capitalization | 287M 3.44M 4.73M |
---|---|---|---|---|---|
Net income 2022 | 44M 527K 727K | Net income 2023 | - 0 0 | EV / Sales 2022 | 3.53 x |
Net Debt 2022 | 22.78M 273K 376K | Net Debt 2023 | 9.64M 116K 159K | EV / Sales 2023 | 2.05 x |
P/E ratio 2022 |
15
x | P/E ratio 2023 |
-309
x | Employees | 105 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.57% |
1 day | +1.56% | ||
1 week | +8.05% | ||
Current month | +4.84% | ||
1 month | +4.84% | ||
3 months | -1.84% | ||
6 months | -10.12% | ||
Current year | -17.05% |
Managers | Title | Age | Since |
---|---|---|---|
Pankaj J. Shah
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - | |
Krupali Shah
CMP | Compliance Officer | - | 23-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 18-10-26 | |
Chairman | 73 | 17-01-31 | |
Director/Board Member | 69 | 15-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 32.5 | +1.56% | 447 |
24-04-29 | 32 | +1.27% | 189 |
24-04-26 | 31.6 | -2.14% | 280 |
24-04-25 | 32.29 | +4.84% | 1,136 |
24-04-24 | 30.8 | +0.52% | 380 |
Delayed Quote Bombay S.E., April 30, 2024 at 06:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
-17.05% | 3.95M | |
-17.66% | 8.43B | |
+39.49% | 3.62B | |
-38.71% | 2.61B | |
-8.06% | 2.48B | |
-7.96% | 2.34B | |
-13.97% | 1.94B | |
-19.73% | 1.56B | |
-40.78% | 1.26B | |
+8.32% | 1.1B |
- Stock Market
- Equities
- ASPIRA Stock